Active Implantable Medical Devices Market by Product (Cardiac Pacemakers, Implantable Cardioverter Defibrillators, Nerve Stimulators, Cochlear Implants, Ventricular Assist Devices, and Implantable Cardiac Devices), by Application (Cardiovascular, Neurological, Hearing Impairment, and Others), and by End User (Hospitals, Specialty Clinics, & ASCs)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020 – 2029

                                          
Abstract
                    
The report covers forecast and analysis for the active implantable medical devices market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the active implantable medical devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the active implantable medical devices market on a global level.

In order to give the users of this report a comprehensive view of the active implantable medical devices market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service type launch, agreements, partnerships, collaborations & joint ventures, research & development, service type and regional expansion of major participants involved in the market.

The study provides a decisive view of the active implantable medical devices market by segmenting it into the product, application, end user and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecasts demand North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further categorized into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for active implantable medical devices market based on all segments in all the regions and countries.

The key players in the global active implantable medical devices market are Abbott Laboratories, Boston Scientific Corp., Cochlear Ltd., LivaNova Plc., Medtronic Plc, Sonova Holding AG, Nurotron Biotechnology Co.Ltd., William Demant Holding A/S, BIOTRONIK SE, and MED-EL.

This report segments the global active implantable medical devices market as follows:

Global Active Implantable Medical Devices Market: Product Segment Analysis

	Cardiac Pacemakers
	
		Single Chamber Pacemakers
		Dual Chamber Pacemakers
		Others
	
	
	Implantable Cardioventer Defibrillators (ICD)
	
		Transvenous ICD
		Subcutaneous ICD
	
	
	Nerve Simulators
	
		Spinal Cord Simulators
		Deep Brain Simulators
		Sacral Nerve Simulators
		Vagus Nerve Simulators
		Gastric Electrical Simulators
	
	
	Cochlear Implants
	Ventricular Assist Devices

Global Active Implantable Medical Devices Market: Application Segment Analysis

	Cardiovascular
	Neurological
	Hearing impairment
	Others 

Global Active Implantable Medical Devices Market: End-User Segment Analysis

	Hospitals
	Specialty Clinics
	Ambulatory Surgical Centers

Global Active Implantable Medical Devices Market: Regional Segment Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa